多剤癌治療 - Shiwarts, Laurent

Title:

多剤癌治療

Document Type and Number:

Japanese Patent JP2008505960

Kind Code:

A

Abstract:

The invention concerns a pharmaceutical composition for treating cancer characterized in that it comprises a combination of a PP2A methylating agent and an active principle selected among the group consisting of a phosphatase PP1 inhibitor, a histone diacetylase inhibitor, a direct or indirect pyruvate kinase activator, a PTEN agonist, a tyrosine kinase inhibitor, a PI3 kinase inhibitor, a glucose competitor, a phosphocnol pyruvate carboxykinase inhibitor, a citrate synthase inhibitor and a latctate dehydro-genase inhibitor.

More Like This:

WO/2019/061791	COMPOUND REPRESENTED BY FORMULA I AND USE THEREOF
JP2013540122	Condensed tetracyclic compound derivatives and how to use them for the treatment of viral diseases
JP2019513373	Neoantigen and how to use it

Inventors:

Shiwarts, Laurent
Maurice, Israel

Application Number:

JP2007520862A

Publication Date:

February 28, 2008

Filing Date:

July 12, 2005

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Shiwarts, Laurent

International Classes:

A61K45/06; A61K31/00; A61K31/155; A61K31/19; A61K31/194; A61K31/198; A61K31/205; A61K31/4439; A61P35/00

Attorney, Agent or Firm:

Yoshio Kawaguchi
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura

Previous Patent: 大粒径のカラートラベル効果顔料を有する化粧用粉末組成物

Next Patent: ボツリヌス神経毒を含む医薬組成物